Weight loss is associated with increased NAD+/SIRT1 expression but reduced PARP activity in white adipose tissue

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 3, 2016, Pages 1263-1273

  Rappou, Elisabeth ^a   Jukarainen, Sakari ^a   Rinnankoski Tuikka, Rita ^a   Kaye, Sanna ^a   Heinonen, Sini ^a   Hakkarainen, Antti ^a   Lundbom, Jesper ^a,b   Lundbom, Nina ^a   Saunavaara, Virva ^c   Rissanen, Aila ^a   Virtanen, Kirsi A ^c   Pirinen, Eija ^a   Pietiläinen, Kirsi H ^a,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SIRTUIN 1; CYTOKINE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN; SIRT1 PROTEIN, HUMAN; SIRTUIN;

ARTICLE; BODY MASS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WEIGHT GAIN; WEIGHT REDUCTION; WEIGHT REGAIN; WHITE ADIPOSE TISSUE; ADULT; CONTROLLED CLINICAL TRIAL; COUNSELING; DOWN REGULATION; GENETICS; LOW CALORY DIET; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; UPREGULATION;

ADIPOSE TISSUE, WHITE; ADULT; COUNSELING; CYTOKINES; DIET, REDUCING; DOWN-REGULATION; FEMALE; HUMANS; MALE; NAD; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION; SIRTUIN 1; SIRTUINS; SUBCUTANEOUS FAT; UP-REGULATION; WEIGHT LOSS;

EID: 84960856109     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3054     Document Type: Article

References (40)

1. Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33(7):673-689.
2. Naukkarinen J, Heinonen S, Hakkarainen A, et al. Characterising metabolically healthy obesity in weight-discordant monozygotic twins. Diabetologia. 2014;57(1):167-176.
3. Heinonen S, Buzkova J, Muniandy M, et al. Impaired mitochondrial biogenesis in adipose tissue in acquired obesity. Diabetes. 2015;64: 3135-3145.
4. Huang C-J, Mc Allister MJ, Slusher AL, Webb HE, Mock JT, Acevedo EO. Obesity-related oxidative stress: the impact of physical activity and diet manipulation. Sport Med Open. 2015;1(1):32.
5. Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol. 2012;13(4):225-238.
6. Bai P, Cantó C, Oudart H, et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 2011; 13(4):461-468.
7. Coste A, Louet JF, Lagouge M, et al. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1a. Proc Natl Acad Sci USA. 2008;105(44): 17187-17192.
8. Yoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice. Cell Metab. 2011;14(4): 528-536.
9. Bordone L, Cohen D, Robinson A, et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell. 2007;6(6): 759-767.
10. Feige JN, Lagouge M, Canto C, et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 2008;8(5): 347-358.
11. Jimenez-Gomez Y, Mattison JA, Pearson KJ, et al. Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. Cell Metab. 2013;18(4):533-545.
12. Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14(5):612-622.
13. Palacios OM, Carmona JJ, Michan S, et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1a in skeletal muscle. Aging (Albany NY). 2009;1(9):771-783.
14. Buler M, Aatsinki SM, Izzi V, Uusimaa J, Hakkola J. SIRT5 is under the control of PGC-1 and AMPK and is involved in regulation of mitochondrial energy metabolism. FASEB J. 2014;28(7):3225-3237.
15. Kanfi Y, Peshti V, Gil R, et al. SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell. 2010;9(2):162-173.
16. Ryu D, Jo YS, Lo Sasso G, et al. A SIRT7-dependent acetylation switch of GABPβ1 controls mitochondrial function. Cell Metab. 2014;20(5):856-869.
17. Bai P, Canto C, Brunyánszki A, et al. PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab. 2011; 13(4):450-460.
18. Pirinen E, Cantó C, Jo YS, et al. Pharmacological inhibition of poly-(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab. 2014;19(6):1034-1041.
19. Civitarese AE, Carling S, Heilbronn LK, et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 2007;4(3):e76.
20. Crujeiras AB, Parra D, Goyenechea E, Martínez JA. Sirtuin gene expression in human mononuclear cells is modulated by caloric restriction. Eur J Clin Invest. 2008;38(9):672-678.
21. Moschen AR, Wieser V, Gerner RR, et al. Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity. J Hepatol. 2013;59(6):1315-1322.
22. Pietiläinen KH, Kaye S, Karmi A, Suojanen L, Rissanen A, Virtanen KA. Agreement of bioelectrical impedance with dual-energy X-ray absorptiometry and MRI to estimate changes in body fat, skeletal muscle and visceral fat during a 12-month weight loss intervention. Br J Nutr. 2013;109:1910-1916.
23. Hannukainen JC, Borra R, Linderborg K, et al. Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activity. J Hepatol. 2011;54(3):545-552.
24. Orava J, Nuutila P, Noponen T, et al. Blunted metabolic responses to cold and insulin stimulation in brown adipose tissue of obese humans. Obesity. 2013;21(11):2279-2287.
25. Lundbom J, Hakkarainen A, Söderlund S, Westerbacka J, Lundbom N, Taskinen MR. Long-TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat. NMR Biomed. 2011; 24(3):238-245.
26. Heinonen S, Saarinen L, Naukkarinen J, et al. Adipocyte morphology and implications for metabolic derangements in acquired obesity. Int J Obes (Lond). 2014;38:1423-1431.
27. Hirschey MD, Shimazu T, Huang JY, Schwer B, Verdin E. SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb Symp Quant Biol. 2011;76:267-277.
28. Clark SJ, Falchi M, Olsson B, et al. Association of sirtuin 1 (SIRT1) gene SNPs and transcript expression levels with severe obesity. Obesity. 2012;20(1):178-185.
29. Song YS, Lee SK, Jang YJ, et al. Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes. Diabetes Res Clin Pract. 2013;101(3):341-348.
30. Guillot C, Favaudon V, Herceg Z, et al. PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models. BMC Cancer. 2014;14(1):603.
31. Varma V, Yao-Borengasser A, Rasouli N, et al. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab. 2007;92(2):666-672.
32. Pagano C, Pilon C, Olivieri M, et al. Reduced plasma Visfatin/Pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab. 2006;91(8):3165-3170.
33. Hayashida S, Arimoto A, Kuramoto Y, et al. Fasting promotes the expression of SIRT1, an NAD+-dependent protein deacetylase, via activation of PPARa in mice. Mol Cell Biochem. 2010;339(1-2): 285-292.
34. Koubova J, Guarente L. How does calorie restriction work? Genes Dev. 2003;17(3):313-321.
35. Fontana L, Meyer TE, Klein S, Holloszy JO. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci USA. 2004;101(17):6659-6663.
36. Cohen HY, Miller C, Bitterman KJ, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004;305(5682):390-392.
37. Pedersen SB, Ølholm J, Paulsen SK, Bennetzen MF, Richelsen B. Low Sirt1 expression, which is upregulated by fasting, in human adipose tissue from obese women. Int J Obes. 2008;32(8):1250-1255.
38. Fulco M, Cen Y, Zhao P, et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-me-diated regulation of Nampt. Dev Cell. 2008;14(5):661-673.
39. Rutanen J, Yaluri N, Modi S, et al. SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity. Diabetes. 2010;59:829-835.
40. Boutant M, Joffraud M, Kulkarni SS, et al. SIRT1 enhances glucose tolerance by potentiating brown adipose tissue function. Mol Metab. 2015;4(2):118-131.